Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Explore the retirement accounts that yield the highest returns. Make informed decisions to grow your retirement savings effectively.
25,325 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Claudia Sahm, a former Federal Reserve economist and creator of a recession signal, says Kevin Warsh’s policy views c...
Providence faces a pivotal September primary as the rent stabilization fracas shapes the mayoral contest. The council...
Researchers unveil an autonomous AI-driven worm that can learn and spread across networks without human input, signal...
The Gedalje Group climbs to the top 10 in RealTrends' 2026 The Thousand rankings after closing 468 sides and $245 mil...
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...
Illinois embeds a first-of-its-kind 0.2% tax on digital asset activity in its $55.9 billion budget, set to take effec...
SpaceX stock shines in the headlines, but the math behind the hype isn’t adding up for me. Here are four practical re...
HomeServices of America and Douglas Elliman scored legal wins this week as they push forward with nationwide homebuye...
The market buzz around Sweetgreen stock is loud, but hype isn’t a plan. This article weighs momentum against business...
Circle Internet Group stock endured a dramatic 45% decline last month amid crypto headlines, new stablecoin competiti...